“Efficacy of transcutaneous retrobulbar amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: A single-center retrospective observational study”. (2025) Student’s Journal of Health Research Africa, 6(12), p. 8. doi:10.51168/sjhrafrica.v7i3.2192.